Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Donia, A. F.
Right arrow Articles by Sobh, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donia, A. F.
Right arrow Articles by Sobh, M. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 2054-2058
© 2003 European Renal Association-European Dialysis and Transplant Association

Original Article

Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children

Ahmed F. Donia, Sanaa H. Gazareen, Hassan A. Ahmed, Fatma E. Moustafa, Ahmed A. Shoeib, Amani M. Ismail, Said Khamis and Mohamed A. Sobh

Urology and Nephrology Center, Mansoura University, Mansoura, Egypt

Correspondence and offprints to: Professor Dr Mohamed A. Sobh, MD, FACP, Professor and Head of Nephrology Department, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt. Email: afdonia{at}hotmail.com

Background. In minimal change nephrotic syndrome (MNCS), the most common primary nephrotic syndrome in children, ~95% of cases show excellent responses to steroid therapy. However, responding patients may become steroid dependent and experience serious side effects. Although oral cyclophosphamide has been recommended in these patients, long-term side effects such as gonadal toxicity are an important concern. Therefore, cyclophosphamide pulses given intravenously may provide an option that maintains remission with less-frequent side effects.

Methods. We treated 20 primary steroid-dependent MCNS patients (15 boys and five girls) with intravenous cyclophosphamide. The patients were children with ages ranging from 3 to 15 years of age. Remission was induced by steroids followed by cyclophosphamide at a dose of 500 mg/m2 body surface area per month for 6 months. During this period, we attempted to completely withdraw steroids and maintain patients on cyclophosphamide alone. We monitored the patients for the occurrence of relapse and side effects during this period and for an additional 6 months after withdrawal of cyclophosphamide.

Results. At the end of the 6-month cyclophosphamide treatment period (i.e. 4 months after steroid discontinuation), nine patients (45%) were in remission on cyclophosphamide alone. However, patients that maintained treatment-free remission (cyclophosphamide responders) decreased to five (25%), two (10%) and one (5%) at 6 months, 1 year and 2 years, respectively.

Conclusion. We found that a 6-month course of pulse cyclophosphamide produced unfavourable effects in the majority of paediatric patients with steroid-dependent nephrotic syndrome.

Keywords: children; cyclophosphamide; minimal change; steroid dependent


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
Z. Bircan
Steroid-dependent nephrotic syndrome and cyclophosphamide
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1327 - 1327.
[Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Donia and M. Sobh
Reply
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1328 - 1328.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.